Tools commonly used in the Blood Banks & Centers industry for day-to-day tasks and operations.

• Blood collection bags
• Blood collection tubes
• Blood typing reagents
• Centrifuges
• Hematology analyzers
• Blood bank refrigerators
• Blood bank freezers
• Blood irradiators
• Blood transport containers
• Donor management software

Common products and services typical of NAICS Code 621991-01, illustrating the main business activities and contributions to the market.

• Blood donation centers
• Hospital blood banks
• Community blood centers
• Plasma donation centers
• Cord blood banks
• Blood component preparation centers
• Blood testing laboratories
• Blood transfusion services
• Blood mobile units
• Blood storage and distribution centers

The specific certifications, permits, licenses, and regulatory compliance requirements within the United States for this industry.

• AABB Accreditation: AABB (formerly known as the American Association of Blood Banks) is an international organization that accredits blood banks and transfusion services. AABB accreditation ensures that the blood bank or center meets the highest standards of quality and safety. The accreditation process includes an on-site assessment of the facility, staff, and procedures. AABB accreditation is required by many hospitals and healthcare facilities in the US.
• Clinical Laboratory Improvement Amendments (CLIA) Certification: CLIA certification is required for all laboratories that perform testing on human specimens for the purpose of diagnosis, treatment, or prevention of disease. Blood banks and centers are included in this requirement. CLIA certification ensures that the laboratory meets federal standards for quality and safety.
• Food and Drug Administration (FDA) Registration: Blood banks and centers must register with the FDA to manufacture and distribute blood products. The FDA regulates the safety and efficacy of blood products in the US.
• State Licensure: Blood banks and centers must be licensed by the state in which they operate. State licensure ensures that the blood bank or center meets state-specific requirements for quality and safety. Varies by state
• College Of American Pathologists (CAP) Accreditation: CAP is an international organization that accredits laboratories, including blood banks and centers. CAP accreditation ensures that the laboratory meets the highest standards of quality and safety.

A concise historical narrative of NAICS Code 621991-01 covering global milestones and recent developments within the United States.

• The history of the Blood Banks & Centers industry dates back to the early 20th century when the first blood transfusion was performed in 1901. The first blood bank was established in 1937 by Dr. Bernard Fantus at Cook County Hospital in Chicago. During World War II, blood banks played a crucial role in saving the lives of wounded soldiers. In 1948, the American Association of Blood Banks was formed to establish standards for blood banks and promote voluntary blood donation. In the 1970s, the first automated blood collection and processing systems were introduced, which increased the efficiency of blood banks. In recent years, blood banks have faced challenges due to the emergence of new diseases such as HIV and hepatitis C, which have led to stricter regulations and testing procedures. In the United States, the history of the Blood Banks & Centers industry has been marked by significant advancements in technology and regulation. In 1983, the FDA implemented regulations requiring blood banks to test all donated blood for HIV. In 1992, the FDA implemented regulations requiring blood banks to test all donated blood for hepatitis C. In 2003, the FDA implemented regulations requiring blood banks to test all donated blood for West Nile virus. In recent years, blood banks have faced challenges due to a decline in blood donations, which has led to shortages of certain blood types. To address this issue, blood banks have implemented new strategies to encourage blood donation, such as mobile blood drives and social media campaigns.

The anticipated future trajectory of the NAICS 621991-01 industry in the USA, offering insights into potential trends, innovations, and challenges expected to shape its landscape.

• Growth Prediction: Stable

  According to a report by ResearchAndMarkets.com, the global blood and organ bank market is expected to grow at a CAGR of 5.6% from 2020 to 2027. The increasing prevalence of chronic diseases, rising demand for blood components and plasma-derived medicines, and the growing number of trauma cases are some of the factors driving the growth of the industry. Additionally, the increasing number of organ transplant procedures and the rising awareness about blood donation are expected to contribute to the growth of the industry. However, the shortage of skilled professionals and the high cost of maintaining blood banks and organ transplant centers may hinder the growth of the industry.

Recent groundbreaking advancements and milestones in the Blood Banks & Centers industry, reflecting notable innovations that have reshaped its landscape.

• Blood Donation Apps: Several blood banks and centers have developed mobile apps that allow donors to schedule appointments, track their donation history, and receive notifications when their blood is used to help someone in need.
• Automated Blood Collection Systems: These systems use advanced technology to collect blood from donors more efficiently and with less discomfort. They also reduce the risk of human error and contamination.
• Pathogen Reduction Technology: This technology uses ultraviolet light and other methods to reduce the risk of transmitting infections through blood transfusions.
• 3D Printing Of Organs: Researchers are exploring the use of 3D printing technology to create organs for transplant. While this technology is still in the early stages of development, it has the potential to revolutionize the field of organ transplantation.
• Gene Editing: Scientists are using gene editing technology to create blood cells that are resistant to certain diseases, such as sickle cell anemia. This could lead to more effective treatments for these conditions and reduce the demand for blood transfusions.